{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:04:49Z","timestamp":1793459089125,"version":"4.5.0"},"reference-count":178,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.neurol.2018.08.004","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T09:36:35Z","timestamp":1537522595000},"page":"628-643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":213,"title":["The genetic landscape of Parkinson's disease"],"prefix":"10.1016","volume":"174","author":[{"given":"A.","family":"Lunati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lesage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Brice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2018.08.004_bib0895","first-page":"9","article-title":"Alzheimer's Disease and Parkinson's Disease","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2018.08.004_bib0900","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/jnnp.2006.100107","article-title":"Estimated life expectancy of Parkinson's patients compared with the UK population","volume":"78","author":"Ishihara","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2018.08.004_bib0905","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2018.08.004_bib0910","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neurobiolaging.2003.04.001","article-title":"Poor and protracted myelination as a contributory factor to neurodegenerative disorders","volume":"25","author":"Braak","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2018.08.004_bib0915","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng1769","article-title":"High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease","volume":"38","author":"Bender","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib0920","doi-asserted-by":"crossref","first-page":"11011","DOI":"10.1523\/JNEUROSCI.2519-09.2009","article-title":"Robust pacemaking in substantia nigra dopaminergic neurons","volume":"29","author":"Guzman","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2018.08.004_bib0925","doi-asserted-by":"crossref","first-page":"10736","DOI":"10.1074\/jbc.R112.410530","article-title":"Calcium, bioenergetics, and neuronal vulnerability in Parkinson's disease","volume":"288","author":"Surmeier","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurol.2018.08.004_bib0930","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the -Synuclein Gene Identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neurol.2018.08.004_bib0935","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease","volume":"44","author":"Pais\u00e1n-Ruiz","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2018.08.004_bib0940","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1126\/science.aar5683","article-title":"LRRK2 kinase in Parkinson's disease","volume":"360","author":"Alessi","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.neurol.2018.08.004_bib0945","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMc055540","article-title":"LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs","volume":"354","author":"Lesage","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2018.08.004_bib0950","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/jmg.2008.062612","article-title":"Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease","volume":"46","author":"Lesage","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib0955","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ng.3043","article-title":"Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease","volume":"46","author":"International Parkinson's Disease Genomics Consortium (IPDGC)","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib0960","doi-asserted-by":"crossref","first-page":"2656e17","DOI":"10.1016\/j.neurobiolaging.2014.05.025","article-title":"Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease","volume":"35","author":"Hatano","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2018.08.004_bib0965","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00702-009-0303-0","article-title":"The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews","volume":"116","author":"Thaler","year":"2009","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neurol.2018.08.004_bib0970","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib0975","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/archneur.63.9.1242","article-title":"Clinical heterogeneity of the LRRK2 G2019S mutation","volume":"63","author":"Papapetropoulos","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib0980","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jns.2018.03.025","article-title":"Motor and non-motor features of Parkinson's disease in LRRK2 G2019S carriers versus matched controls","volume":"388","author":"Gunzler","year":"2018","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2018.08.004_bib0985","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ana.20456","article-title":"Clinical features of LRRK2-associated Parkinson's disease in central Norway","volume":"57","author":"Aasly","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib0990","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(05)17829-5","article-title":"A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease","volume":"365","author":"Di Fonzo","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2018.08.004_bib0995","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1212\/01.wnl.0000326575.20829.45","article-title":"Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data","volume":"71","author":"Silveira-Moriyama","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.08.004_bib1000","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neulet.2009.10.080","article-title":"A novel LRRK2 mutation in a mainland Chinese patient with familial Parkinson's disease","volume":"468","author":"Wang","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurol.2018.08.004_bib1005","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/humu.22075","article-title":"Deep sequencing of the LRRK2 gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe","volume":"33","author":"Rubio","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.neurol.2018.08.004_bib1010","first-page":"85","article-title":"LRRK2: cause, risk, and mechanism","author":"Coro","year":"2013","journal-title":"J Park Dis"},{"key":"10.1016\/j.neurol.2018.08.004_bib1015","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/432422","article-title":"LRRK2 Haplotype analyses in European and North African families with Parkinson disease: a common founder for the G2019S mutation dating from the 13th century","volume":"77","author":"Lesage","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1020","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/mds.27059","article-title":"Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry: LRRK2 Mutation in Non-Ashkenazi Jewish Ancestry","volume":"32","author":"Lee","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1025","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/mds.25600","article-title":"Population-specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO-PD) consortium: frequency of LRRK2 Variants in PD","volume":"28","author":"Heckman","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1030","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/mds.27193","article-title":"Neuropathology of genetic synucleinopathies with parkinsonism: review of the literature","volume":"32","author":"Schneider","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1035","series-title":"\u03b1-Synuclein Promotes SNARE-Complex Assembly in vivo and in vitro","first-page":"14","author":"Burr\u00e9","year":"2011"},{"key":"10.1016\/j.neurol.2018.08.004_bib1040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1212\/01.wnl.0000271080.53272.c7","article-title":"-Synuclein gene duplication is present in sporadic Parkinson disease","volume":"70","author":"Ahn","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.08.004_bib1045","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1212\/01.wnl.0000338439.00992.c7","article-title":"-Synuclein gene duplication is present in sporadic Parkinson disease","volume":"71","author":"Brueggemann","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.08.004_bib1050","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1093\/hmg\/ddp012","article-title":"Parkinson's disease: from monogenic forms to genetic susceptibility factors","volume":"18","author":"Lesage","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11910-017-0737-y","article-title":"\u03b1-Synuclein and Parkinsonism: updates and future perspectives","volume":"17","author":"Rosborough","year":"2017","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.neurol.2018.08.004_bib1060","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/archneurol.2008.555","article-title":"\u03b1-Synuclein gene rearrangements in dominantly inherited Parkinsonism: frequency, phenotype, and mechanisms","volume":"66","author":"Ib\u00e1\u00f1ez","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1065","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/mds.25499","article-title":"The many faces of alpha-synuclein mutations: the many faces of Alpha-Synuclein mutations","volume":"28","author":"Kasten","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/mds.26549","article-title":"The Contursi family 20 years later: intrafamilial phenotypic variability of the SNCA p.A53T mutation","volume":"31","author":"Ricciardi","year":"2016","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1075","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1212\/WNL.56.10.1355","article-title":"Familial parkinsonism with synuclein pathology: clinical and PET studies of A30P mutation carriers","volume":"56","author":"Kr\u00fcger","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.08.004_bib1080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of \u03b1-synuclein causes parkinson and Lewy body dementia: New \u03b1-Synuclein Gene Mutation","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1085","first-page":"10","article-title":"Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation","author":"Kiely","year":"2015","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.neurol.2018.08.004_bib1090","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.23894","article-title":"G51D \u03b1-synuclein mutation causes a novel Parkinsonian-pyramidal syndrome: SNCA G51D in Parkinsonism","volume":"73","author":"Lesage","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1095","doi-asserted-by":"crossref","first-page":"2180e1","DOI":"10.1016\/j.neurobiolaging.2014.03.024","article-title":"A novel \u03b1-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology","volume":"35","author":"Pasanen","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2018.08.004_bib1100","first-page":"1","article-title":"Clinical and imaging findings in Parkinson disease associated with the A53E SNCA mutation","author":"Martikainen","year":"2015","journal-title":"Neurol Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1105","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/mds.25421","article-title":"Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease: \u03b1- Synuclein p.H50q, a novel mutation For Pd","volume":"28","author":"Appel-Cresswell","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1110","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1212\/WNL.0b013e31828727ba","article-title":"A novel -synuclein missense mutation in Parkinson disease","volume":"80","author":"Proukakis","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.08.004_bib1115","doi-asserted-by":"crossref","first-page":"159e5","DOI":"10.1016\/j.neurobiolaging.2017.12.012","article-title":"Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson's disease","volume":"64","author":"Blauwendraat","year":"2018","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2018.08.004_bib1120","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jama.296.6.661","article-title":"Collaborative analysis of \u03b1-Synuclein gene promoter variability and Parkinson disease","volume":"296","author":"Maraganore","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.neurol.2018.08.004_bib1125","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1093\/hmg\/ddx179","article-title":"Vps35 in cooperation with LRRK2 regulates synaptic vesicle endocytosis through the endosomal pathway in Drosophila","volume":"26","author":"Inoshita","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1130","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajhg.2011.06.001","article-title":"VPS35 mutations in Parkinson disease","volume":"89","author":"Vilari\u00f1o-G\u00fcell","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1135","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ajhg.2011.06.008","article-title":"A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease","volume":"89","author":"Zimprich","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1140","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3892\/mmr.2017.6551","article-title":"High expression levels of the D686N Parkinson's disease mutation in VPS35 induces \u03b1-synuclein-dependent toxicity in yeast","volume":"16","author":"Huang","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.neurol.2018.08.004_bib1145","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0b013e318253d5f2","article-title":"Identification of VPS35 mutations replicated in French families with Parkinson disease","volume":"78","author":"Lesage","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.08.004_bib1150","doi-asserted-by":"crossref","first-page":"838e1","DOI":"10.1016\/j.neurobiolaging.2011.10.032","article-title":"Screening for VPS35 mutations in Parkinson's disease","volume":"33","author":"Sheerin","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2018.08.004_bib1155","first-page":"17","article-title":"Identification of VPS35 p.D620N mutation-related Parkinson's disease in a Taiwanese family with successful bilateral subthalamic nucleus deep brain stimulation: a case report and literature review","author":"Chen","year":"2017","journal-title":"BMC Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1160","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/mds.25145","article-title":"VPS35 mutation in Japanese patients with typical Parkinson's disease","volume":"27","author":"Ando","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1165","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00702-014-1179-1","article-title":"VPS35 Parkinson's disease phenotype resembles the sporadic disease","volume":"121","author":"The Austrian VPS-35 Investigators Team","year":"2014","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neurol.2018.08.004_bib1170","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/brain\/awp084","article-title":"Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia","volume":"132","author":"Clot","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2018.08.004_bib1175","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1093\/brain\/awu179","article-title":"Parkinson's disease in GTP cyclohydrolase 1 mutation carriers","volume":"137","author":"Mencacci","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2018.08.004_bib1180","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1212\/WNL.41.6.820","article-title":"New pathologic observations in juvenile onset parkinsonism with dystonia","volume":"41","author":"Gibb","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.08.004_bib1185","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1093\/brain\/awu341","article-title":"Parkinsonism in GTP cyclohydrolase 1 mutation carriers","volume":"138","author":"Guella","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2018.08.004_bib1190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archneur.61.1.35","article-title":"The Parkinsonian Phenotype of Spinocerebellar Ataxia Type 2","volume":"61","author":"Lu","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1195","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1212\/01.wnl.0000269323.21969.db","article-title":"Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism?","volume":"69","author":"Charles","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.08.004_bib1200","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.parkreldis.2017.04.003","article-title":"SCA2 family presenting as typical Parkinson's disease: 34 year follow-up","volume":"40","author":"Kim","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1205","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/mds.10375","article-title":"SCA2 may present as levodopa-responsive parkinsonism","volume":"18","author":"Payami","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1210","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/WNL.55.6.800","article-title":"Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese","volume":"55","author":"Gwinn-Hardy","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.08.004_bib1215","article-title":"Spinocerebellar ataxia type 2 is associated with Parkinsonism and Lewy body pathology","volume":"2011","author":"Takao","year":"2011","journal-title":"Case Rep"},{"key":"10.1016\/j.neurol.2018.08.004_bib1220","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/125273","article-title":"Parkinsonism in Spinocerebellar Ataxia","author":"Park","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.neurol.2018.08.004_bib1225","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/hmg\/ddt570","article-title":"DNAJC13 mutations in Parkinson disease","volume":"23","author":"Vilari\u00f1o-G\u00fcell","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1230","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/mds.26019","article-title":"Clinical, positron emission tomography, and pathological studies of DNAJC13 p.N855S Parkinsonism","volume":"29","author":"Appel-Cresswell","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1235","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2018.06.004","article-title":"DNAJC13\u00a0mutation screening in patients with Parkinson's disease from South Italy","author":"Gagliardi","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1240","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ng.3589","article-title":"Identification of TMEM230\u00a0mutations in familial Parkinson's disease","volume":"48","author":"Deng","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1245","first-page":"3","article-title":"Novel gene (TMEM230) linked to Parkinson's disease","author":"Olszewska","year":"2016","journal-title":"J Clin Mov Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1250","doi-asserted-by":"crossref","first-page":"239e9","DOI":"10.1016\/j.neurobiolaging.2017.06.011","article-title":"Screening for TMEM230\u00a0mutations in young-onset Parkinson's disease","volume":"58","author":"Ma","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2018.08.004_bib1255","doi-asserted-by":"crossref","first-page":"167e11","DOI":"10.1016\/j.neurobiolaging.2016.10.004","article-title":"Lack of evidence for a role of genetic variation in TMEM230 in the risk for Parkinson's disease in the Caucasian population","volume":"50","author":"Giri","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2018.08.004_bib1260","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ajhg.2008.01.015","article-title":"Mutations in the GIGYF2 (TNRC15) Gene at the PARK11 Locus in Familial Parkinson Disease","volume":"82","author":"Lautier","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1265","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1468-1331.2009.02834.x","article-title":"Summary of GIGYF2 studies in Parkinson's disease: the burden of proof","volume":"17","author":"Tan","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1270","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.neurobiolaging.2009.06.008","article-title":"Follow-up study of the GIGYF2\u00a0gene in French families with Parkinson's disease","volume":"31","author":"Lesage","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2018.08.004_bib1275","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.parkreldis.2009.01.005","article-title":"PARK11 gene (GIGYF2) variants Asn56Ser and Asn457Thr are not pathogenic for Parkinson's disease","volume":"15","author":"Zimprich","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1280","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/jhg.2015.69","article-title":"GIGYF2 mutation in late-onset Parkinson's disease with cognitive impairment","volume":"60","author":"Ruiz-Martinez","year":"2015","journal-title":"J Hum Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1285","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1474-4422(04)00681-7","article-title":"Insulin and neurodegenerative disease: shared and specific mechanisms","volume":"3","author":"Craft","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1290","doi-asserted-by":"crossref","first-page":"9848","DOI":"10.1128\/MCB.24.22.9848-9862.2004","article-title":"Neuroprotective role of the reaper-related serine protease HtrA2\/Omi revealed by targeted deletion in mice","volume":"24","author":"Martins","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1295","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.parkreldis.2008.08.003","article-title":"Genetic variation of Omi\/HtrA2 and Parkinson's disease","volume":"14","author":"Ross","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1300","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/hmg\/ddi215","article-title":"Loss of function mutations in the gene encoding Omi\/HtrA2 in Parkinson's disease","volume":"14","author":"Strauss","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1305","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00439-011-1041-6","article-title":"Novel variant Pro143Ala in HTRA2 contributes to Parkinson's disease by inducing hyperphosphorylation of HTRA2 protein in mitochondria","volume":"130","author":"Lin","year":"2011","journal-title":"Hum Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1310","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.brainres.2011.02.037","article-title":"Genetic variations of Omi\/HTRA2 in Chinese patients with Parkinson's disease","volume":"1385","author":"Wang","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.neurol.2018.08.004_bib1315","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/jmedgenet-2016-103922","article-title":"Deficiency of HTRA2\/Omi is associated with infantile neurodegeneration and 3-methylglutaconic aciduria","volume":"53","author":"Mandel","year":"2016","journal-title":"J Med Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1320","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10545-016-9977-2","article-title":"Pathogenic variants in HTRA2 cause an early-onset mitochondrial syndrome associated with 3-methylglutaconic aciduria","volume":"40","author":"Ol\u00e1hov\u00e1","year":"2017","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.neurol.2018.08.004_bib1325","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2377-12-62","article-title":"UCHL1 S18Y variant is a risk factor for Parkinson's disease in Japan","volume":"12","author":"Miyake","year":"2012","journal-title":"BMC Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1330","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00441-004-0917-3","article-title":"Genetic causes of Parkinson's disease: UCHL-1","volume":"318","author":"Healy","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.neurol.2018.08.004_bib1335","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/aje\/kwp288","article-title":"Association between the Ubiquitin Carboxyl-Terminal Esterase L1 gene (UCHL1) S18Y variant and Parkinson's Disease: a HuGE review and meta-analysis","volume":"170","author":"Ragland","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1340","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/hmg\/ddx072","article-title":"Novel UCHL1 mutations reveal new insights into ubiquitin processing","volume":"26","author":"Rydning","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1345","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s10038-018-0463-6","article-title":"Novel splice-site variant of UCHL1 in an Indian family with autosomal recessive spastic paraplegia-79","volume":"63","author":"Das Bhowmik","year":"2018","journal-title":"J Hum Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1350","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/jmedgenet-2015-103616","article-title":"Evidence of mutations in RIC3 acetylcholine receptor chaperone as a novel cause of autosomal-dominant Parkinson's disease with non-motor phenotypes","volume":"53","author":"Sudhaman","year":"2016","journal-title":"J Med Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1355","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ajhg.2011.08.009","article-title":"Translation initiator EIF4G1 mutations in familial Parkinson disease","volume":"89","author":"Chartier-Harlin","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1360","doi-asserted-by":"crossref","first-page":"2444e1","DOI":"10.1016\/j.neurobiolaging.2015.04.017","article-title":"EIF4G1 mutations do not cause Parkinson's disease","volume":"36","author":"Nichols","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2018.08.004_bib1365","doi-asserted-by":"crossref","first-page":"2233e1","DOI":"10.1016\/j.neurobiolaging.2012.05.006","article-title":"EIF4G1 in familial Parkinson's disease: pathogenic mutations or rare benign variants?","volume":"33","author":"Lesage","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2018.08.004_bib1370","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1474-4422(14)70266-2","article-title":"CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study","volume":"14","author":"Funayama","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1375","doi-asserted-by":"crossref","first-page":"15500","DOI":"10.1038\/ncomms15500","article-title":"Loss of Parkinson's disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c","volume":"8","author":"Meng","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.neurol.2018.08.004_bib1380","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/humu.23234","article-title":"Varied pathological and therapeutic response effects associated with CHCHD2 mutant and risk variants: TIO, et al","volume":"38","author":"Tio","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1016\/j.neurol.2018.08.004_bib1385","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.10.018","article-title":"A novel mutation of CHCHD2 p.R8H in a sporadic case of Parkinson's disease","volume":"34","author":"Ikeda","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1390","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S1474-4422(15)00094-0","article-title":"CHCHD2 and Parkinson's disease","volume":"14","author":"Jansen","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1395","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ajhg.2014.10.015","article-title":"Mutations in RAB39B Cause X-linked intellectual disability and early-onset Parkinson disease with \u03b1-Synuclein Pathology","volume":"95","author":"Wilson","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1400","first-page":"10","article-title":"The RAB39B p.G192R mutation causes X-linked dominant Parkinson's disease","author":"Mata","year":"2015","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.neurol.2018.08.004_bib1405","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ajhg.2010.01.011","article-title":"Mutations in the small GTPase Gene RAB39B are responsible for X-linked mental retardation associated with autism, epilepsy, and macrocephaly","volume":"86","author":"Giannandrea","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1410","first-page":"8","article-title":"Mutations in RAB39B in individuals with intellectual disability, autism spectrum disorder, and macrocephaly","author":"Woodbury-Smith","year":"2017","journal-title":"Mol Autism"},{"key":"10.1016\/j.neurol.2018.08.004_bib1415","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1212\/NXG.0000000000000009","article-title":"Loss-of-function mutations in RAB39B are associated with typical early-onset Parkinson disease","volume":"1","author":"Lesage","year":"2015","journal-title":"Neurol Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1420","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tibs.2015.02.003","article-title":"Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease","volume":"40","author":"Ryan","year":"2015","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.neurol.2018.08.004_bib1425","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/77060","article-title":"Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase","volume":"25","author":"Shimura","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1430","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s001090100242","article-title":"Parkin is linked to the ubiquitin pathway","volume":"79","author":"Tanaka","year":"2001","journal-title":"J Mol Med"},{"key":"10.1016\/j.neurol.2018.08.004_bib1435","doi-asserted-by":"crossref","first-page":"e12962","DOI":"10.1371\/journal.pone.0012962","article-title":"Mutant Parkin impairs mitochondrial function and morphology in human fibroblasts","volume":"5","author":"Gr\u00fcnewald","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neurol.2018.08.004_bib1440","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/brain\/awg136","article-title":"Parkin mutations are frequent in patients with isolated early-onset parkinsonism","volume":"126","author":"Periquet","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2018.08.004_bib1445","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1093\/hmg\/ddi292","article-title":"Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin","volume":"14","author":"Sriram","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1450","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/mds.27352","article-title":"Genotype-phenotype relations for the Parkinson's disease genes Parkin, PINK1, DJ1: MDSGene systematic review: MDSGene REVIEW: Parkin, PINK1, DJ1","volume":"33","author":"Kasten","year":"2018","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1455","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1007\/s12035-017-0535-1","article-title":"A clinical and molecular genetic study of 50 families with autosomal recessive Parkinsonism revealed known and novel gene mutations","volume":"55","author":"Taghavi","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1460","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJM200005253422103","article-title":"Association between Early-Onset Parkinson's disease and mutations in the Parkin gene","volume":"342","author":"L\u00fccking","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2018.08.004_bib1465","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1212\/01.wnl.0000327098.86861.d4","article-title":"A multidisciplinary study of patients with early-onset PD with and without parkin mutations","volume":"72","author":"Lohmann","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.08.004_bib1470","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/brain\/awg142","article-title":"Parkin disease: a phenotypic study of a large case series","volume":"126","author":"Khan","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2018.08.004_bib1475","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1212\/01.WNL.0000118281.66802.81","article-title":"Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease","volume":"62","author":"Khan","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.08.004_bib1480","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.10613","article-title":"How much phenotypic variation can be attributed to parkin genotype? Phenotypic variation of Parkin","volume":"54","author":"Lohmann","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1485","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/jamaneurol.2013.172","article-title":"Parkin disease: a clinicopathologic entity?","volume":"70","author":"Doherty","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1490","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ana.1132","article-title":"Lewy bodies and parkinsonism in families with parkin mutations","volume":"50","author":"Farrer","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1495","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/humu.20436","article-title":"Deletion of the parkin and PACRG gene promoter in early-onset parkinsonism","volume":"28","author":"Lesage","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.neurol.2018.08.004_bib1500","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson's disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neurol.2018.08.004_bib1505","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awq051","article-title":"PINK1-linked parkinsonism is associated with Lewy body pathology","volume":"133","author":"Samaranch","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2018.08.004_bib1510","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset Parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neurol.2018.08.004_bib1515","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ana.10675","article-title":"The role of pathogenicDJ-1 mutations in Parkinson's disease","volume":"54","author":"Abou-Sleiman","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1520","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/mds.25132","article-title":"Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease","volume":"27","author":"Kilarski","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1525","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/brain\/aww080","article-title":"DJ-1 linked parkinsonism (PARK7) is associated with Lewy body pathology","volume":"139","author":"Taipa","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2018.08.004_bib1530","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ng1884","article-title":"Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase","volume":"38","author":"Ramirez","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1535","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1212\/01.wnl.0000260963.08711.08","article-title":"ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease","volume":"68","author":"Di Fonzo","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.08.004_bib1540","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/mds.23221","article-title":"Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations","volume":"25","author":"Pais\u00e1n-Ruiz","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1545","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/mds.22996","article-title":"Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations","volume":"25","author":"Behrens","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1550","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neulet.2014.06.023","article-title":"Identification of p.Gln858* in ATP13A2 in two EOPD patients and presentation of their clinical features","volume":"577","author":"Malakouti-Nejad","year":"2014","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurol.2018.08.004_bib1555","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.parkreldis.2010.10.011","article-title":"Juvenile dystonia-parkinsonism and dementia caused by a novel ATP13A2\u00a0frameshift mutation","volume":"17","author":"Crosiers","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1560","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/mds.22947","article-title":"ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation","volume":"25","author":"Schneider","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1565","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1093\/hmg\/dds089","article-title":"Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis","volume":"21","author":"Bras","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1570","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/brain\/aww307","article-title":"Loss-of-function mutations in the ATP13A2\/PARK9\u00a0gene cause complicated hereditary spastic paraplegia (SPG78)","volume":"140","author":"Estrada-Cuzcano","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2018.08.004_bib1575","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2018.05.019","article-title":"Phospholipase PLA2G6, a Parkinsonism-Associated Gene, Affects Vps26 and Vps35, Retromer Function, and Ceramide Levels, Similar to \u03b1-Synuclein Gain","author":"Lin","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.neurol.2018.08.004_bib1580","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ng1826","article-title":"PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron","volume":"38","author":"Morgan","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1585","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jmg.2008.061929","article-title":"Clinical and genetic delineation of neurodegeneration with brain iron accumulation","volume":"46","author":"Gregory","year":"2008","journal-title":"J Med Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1590","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1212\/01.wnl.0000310986.48286.8e","article-title":"Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN)","volume":"70","author":"Kurian","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.08.004_bib1595","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jns.2017.08.3260","article-title":"A new PLA2G6 mutation in a family with infantile neuroaxonal dystrophy","volume":"381","author":"Grazia","year":"2017","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2018.08.004_bib1600","first-page":"59","article-title":"Genetics and pathophysiology of neurodegeneration with brain iron accumulation (NBIA)","volume":"11","author":"Schneider","year":"2013","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1605","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1468-1331.2008.02356.x","article-title":"R632W mutation in PLA2G6 segregates with dystonia-parkinsonism in a consanguineous Iranian family","volume":"16","author":"Sina","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1610","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ana.21415","article-title":"Characterization of PLA2G6 as a locus for dystonia-parkinsonism","volume":"65","author":"Paisan-Ruiz","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1615","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.neurobiolaging.2010.05.009","article-title":"Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6\u00a0mutations","volume":"33","author":"Pais\u00e1n-Ruiz","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2018.08.004_bib1620","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1212\/WNL.0b013e3181f73649","article-title":"Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism","volume":"75","author":"Yoshino","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.08.004_bib1625","doi-asserted-by":"crossref","first-page":"e12897","DOI":"10.1371\/journal.pone.0012897","article-title":"Catalytic function of PLA2G6\u00a0is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism","volume":"5","author":"Engel","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.neurol.2018.08.004_bib1630","doi-asserted-by":"crossref","first-page":"e36458","DOI":"10.1371\/journal.pone.0036458","article-title":"A deleterious mutation in DNAJC6 encoding the neuronal-specific clathrin-uncoating co-chaperone auxilin, is associated with juvenile Parkinsonism","volume":"7","author":"Edvardson","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neurol.2018.08.004_bib1635","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ana.24553","article-title":"D NAJC 6\u00a0mutations associated with early-onset Parkinson's disease: DNAJC6\u00a0mutations in Parkinson's disease","volume":"79","author":"Olgiati","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1640","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.parkreldis.2012.11.006","article-title":"DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability","volume":"19","author":"K\u00f6ro\u011flu","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1645","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ana.24591","article-title":"A novel nonsense mutation in DNAJC 6 expands the phenotype of autosomal-recessive juvenile-onset Parkinson's disease","volume":"79","author":"Elsayed","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1650","first-page":"9","article-title":"Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1\u00a0mutations","author":"Fasano","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.neurol.2018.08.004_bib1655","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/289728","article-title":"Synaptojanin 1 mutation in Parkinson's disease brings further insight into the neuropathological mechanisms","volume":"2014","author":"Drouet","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.neurol.2018.08.004_bib1660","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1474-4422(18)30179-0","article-title":"LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study","volume":"17","author":"Quadri","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1665","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/humu.22372","article-title":"The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures","volume":"34","author":"Krebs","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.neurol.2018.08.004_bib1670","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/humu.22373","article-title":"Mutation in the SYNJ1 gene associated with autosomal recessive early-onset Parkinsonism","volume":"34","author":"Quadri","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.neurol.2018.08.004_bib1675","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10048-014-0406-0","article-title":"PARK20\u00a0caused by SYNJ1\u00a0homozygous Arg258Gln mutation in a new Italian family","volume":"15","author":"Olgiati","year":"2014","journal-title":"Neurogenetics"},{"key":"10.1016\/j.neurol.2018.08.004_bib1680","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00415-009-0083-3","article-title":"SPG11 spastic paraplegia: a new cause of juvenile parkinsonism","volume":"256","author":"Anheim","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1685","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nn.3489","article-title":"The Parkinson's disease\u2013linked proteins Fbxo7\u00a0and Parkin interact to mediate mitophagy","volume":"16","author":"Burchell","year":"2013","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurol.2018.08.004_bib1690","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/jnc.14253","article-title":"Mechanistic contributions of FBXO7 to Parkinson disease","volume":"144","author":"Joseph","year":"2018","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurol.2018.08.004_bib1695","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1212\/01.wnl.0000338144.10967.2b","article-title":"FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome","volume":"72","author":"Fonzo","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2018.08.004_bib1700","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.ajhg.2008.05.005","article-title":"Genome-wide linkage analysis of a Parkinsonian-Pyramidal Syndrome Pedigree by 500K SNP arrays","volume":"82","author":"Shojaee","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1705","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.parkreldis.2014.06.024","article-title":"A new Turkish family with homozygous FBXO7 truncating mutation and juvenile atypical parkinsonism","volume":"20","author":"Yalcin-Cakmakli","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1710","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.parkreldis.2017.11.332","article-title":"Juvenile-onset parkinsonism with pyramidal signs due to compound heterozygous mutations in the F-Box only protein 7 gene","volume":"47","author":"Wei","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1715","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajhg.2016.01.014","article-title":"Loss of VPS13C function in autosomal-recessive Parkinsonism causes mitochondrial dysfunction and increases PINK1\/Parkin-dependent mitophagy","volume":"98","author":"Lesage","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1720","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/mds.26682","article-title":"VPS13C -another hint at mitochondrial dysfunction in familial Parkinson's disease: hot topics","volume":"31","author":"Schreglmann","year":"2016","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1725","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/jmedgenet-2015-103459","article-title":"Discovery of a frameshift mutation in podocalyxin-like (PODXL) gene, coding for a neural adhesion molecule, as causal for autosomal-recessive juvenile Parkinsonism","volume":"53","author":"Sudhaman","year":"2016","journal-title":"J Med Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1730","first-page":"17","article-title":"New genes causing hereditary Parkinson's disease or Parkinsonism","author":"Puschmann","year":"2017","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.neurol.2018.08.004_bib1735","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/mds.26627","article-title":"Mutation in ADORA1 identified as likely cause of early-onset parkinsonism and cognitive dysfunction","volume":"31","author":"Jaberi","year":"2016","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1740","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/mds.26824","article-title":"PTRHD1 (C2orf79) mutations lead to autosomal-recessive intellectual disability and parkinsonism: PTRHD1 mutation in ID and Parkinsonism","volume":"32","author":"Khodadadi","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1745","first-page":"11","article-title":"Multicenter analysis of Glucocerebrosidase mutations in Parkinson's disease","author":"Sidransky","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2018.08.004_bib1750","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2004.08.015","article-title":"Gaucher disease: complexity in a \u201csimple\u201d disorder","volume":"83","author":"Sidransky","year":"2004","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.neurol.2018.08.004_bib1755","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/mds.25462","article-title":"Lysosomal impairment in Parkinson's disease: Lysosomal Impairment In PD","volume":"28","author":"Dehay","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.08.004_bib1760","doi-asserted-by":"crossref","DOI":"10.1111\/febs.14393","article-title":"The role of glucocerebrosidase in Parkinson disease pathogenesis","author":"Gegg","year":"2018","journal-title":"FEBS J"},{"key":"10.1016\/j.neurol.2018.08.004_bib1765","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awp044","article-title":"Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2018.08.004_bib1770","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/hmg\/ddq454","article-title":"Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease","volume":"20","author":"Lesage","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2018.08.004_bib1775","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","article-title":"The link between the GBA gene and parkinsonism","volume":"11","author":"Sidransky","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2018.08.004_bib1780","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(10)62345-8","article-title":"Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association, studies","volume":"377","year":"2011","journal-title":"Lancet"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378718308063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378718308063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:38:16Z","timestamp":1758519496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378718308063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":178,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0035378718308063"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2018.08.004","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The genetic landscape of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2018.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}